Market open
Edwards Lifesciences/$EW
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Edwards Lifesciences
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Ticker
$EW
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
19,800
Website
EW Metrics
BasicAdvanced
$41B
10.02
$6.89
1.11
-
Price and volume
Market cap
$41B
Beta
1.11
52-week high
$96.12
52-week low
$58.93
Average daily volume
5M
Financial strength
Current ratio
3.461
Quick ratio
2.704
Long term debt to equity
7.101
Total debt to equity
7.353
Interest coverage (TTM)
108.13%
Management effectiveness
Return on assets (TTM)
10.65%
Return on equity (TTM)
19.14%
Valuation
Price to earnings (TTM)
10.016
Price to revenue (TTM)
6.572
Price to book
5.59
Price to tangible book (TTM)
7.08
Price to free cash flow (TTM)
84.675
Growth
Revenue change (TTM)
24.02%
Earnings per share change (TTM)
193.69%
3-year revenue growth (CAGR)
7.42%
3-year earnings per share growth (CAGR)
43.62%
What the Analysts think about EW
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Edwards Lifesciences stock.
EW Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
EW Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
EW News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Edwards Lifesciences stock?
Edwards Lifesciences (EW) has a market cap of $41B as of January 27, 2025.
What is the P/E ratio for Edwards Lifesciences stock?
The price to earnings (P/E) ratio for Edwards Lifesciences (EW) stock is 10.02 as of January 27, 2025.
Does Edwards Lifesciences stock pay dividends?
No, Edwards Lifesciences (EW) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next Edwards Lifesciences dividend payment date?
Edwards Lifesciences (EW) stock does not pay dividends to its shareholders.
What is the beta indicator for Edwards Lifesciences?
Edwards Lifesciences (EW) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.